EN DE

Beauty Farm Medical and Health Industry Inc (2373) Fair Value & Analysis

Healthcare · HK · Market cap HK$4.0B

BF Beauty Farm Medical and Health Industry Inc 2373 · HK
PriceHK$19.48
Fair ValueHK$32.68
Upside+67.8%
Quality67/100
Watch Beauty Farm Medical and Health Industry Inc for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 10.6% net margin
Moderate debt · generates free cash flow
3.73% dividend yield
Ranks above peers (11/14)
Wide moat 65/100
Evidence: High Range HK$24.51 – HK$48.10 Share as image

Fair value as of: Aug 6, 2026

From 26 valuation models · updated 4 days ago

Fair value updated Aug 6, 2026, revised from HK$32.46 to HK$32.68 (+0.7%) since Jul 2, 2026. Share price +9.5% over the past month.

A solid business, screening 68% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (HK$24.51). The market is more pessimistic than our downside scenario.
  • Solid quality (67/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range (HK$24.51 to HK$48.10) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

HK$38.52 HK$8.99 Fair Value HK$32.68 Jan 2023 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 6, 2026.

How to read this chart

43‑month range HK$8.99 – HK$38.52 · fair‑value band HK$24.51 – HK$48.10 · the HK$19.48 price screens below the HK$32.68 fair value. Dashed = 300-day average. As of Aug 6, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Beauty Farm Medical and Health Industry Inc (2373) currently trades at HK$19.48, while our model-based Fair Value estimate is HK$32.68, implying the stock looks roughly 67.8% undervalued today. The Quality Score stands at 67/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Beauty Farm Medical and Health Industry Inc generated revenue of HK$3.0B at a net margin of 10.6%. Revenue grew 7.5% year over year. It earns a return on equity of 33.3%. Net debt stands at HK$156M. Fundamentals as of Aug 6, 2026

Our scenario range runs from HK$24.51 (bear case) to HK$48.10 (bull case); at HK$19.48, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 53% below its 52-week high and 25% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 68%, 2373 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF HK$51.97 HK$101.56 HK$177.89 80
Residual Income HK$8.44 HK$11.36 HK$74.24 76
Rev-Margin DCF HK$29.82 HK$48.39 HK$74.57 74
All 26 models by family
DCF Models
FCF DCF HK$53.67 HK$93.89 HK$194.30 38
Owner Earnings HK$38.32 HK$75.77 HK$146.25 31
5Y Revenue Exit HK$29.82 HK$48.65 HK$74.34 39
5Y EBITDA Exit HK$42.00 HK$76.01 HK$120.84 41
5Y P/E Exit HK$31.84 HK$53.18 HK$78.54 38
10Y Revenue Exit HK$36.62 HK$58.24 HK$91.83 36
10Y EBITDA Exit HK$45.42 HK$78.85 HK$134.08 37
10Y P/E Exit HK$38.59 HK$61.65 HK$96.37 35
Earnings-Based
Graham-Dodd HK$8.69 HK$52.75 HK$73.57 54
Lynch FV HK$15.08 HK$21.54 HK$28.01 50
PEG = 1.0 HK$15.08 HK$21.54 HK$28.01 46
EPV HK$14.80 HK$16.82 HK$18.56 59
Dividend Discount
Gordon GGM HK$4.32 HK$8.61 HK$13.04 70
DDM Multi-Stage HK$4.32 HK$7.44 HK$9.09 61
Multiples
P/E Multiple HK$21.10 HK$28.13 HK$35.16 63
P/S Multiple HK$16.30 HK$21.73 HK$27.17 58
P/B Multiple HK$13.89 HK$18.52 HK$23.15 55
EV/EBIT HK$25.59 HK$33.45 HK$41.31 53
EV/EBITDA HK$38.53 HK$50.71 HK$62.89 54
EV/Revenue HK$18.83 HK$26.05 HK$33.27 43
Asset-Based
NCAV (Graham) HK$2.06 HK$2.76 HK$4.12 50
Growth DCF
Growth DCF HK$51.97 HK$101.56 HK$177.89 80
Rev-Margin DCF HK$29.82 HK$48.39 HK$74.57 74
Economic Profit
Residual Income HK$8.44 HK$11.36 HK$74.24 76
ROIC Compounder HK$16.19 HK$20.13 HK$24.79 72
Growth Earnings
Growth-Adj P/E HK$22.29 HK$31.85 HK$41.40 68

Widest divergence: DCF Models (HK$61.65) versus Asset-Based (HK$2.76). Highest evidence: Growth DCF (80).

Notify me when 2373 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) HK$3.0B
Revenue growth (YoY) +7.5%
Net margin 10.6%
Return on equity 33.3%
Free cash flow HK$932M FY2025
P/E ratio 10.1
More key figures
Operating margin 15.5%
EPS (TTM) HK$0.6800
Dividend yield 3.7%
EPS growth (YoY) +40.8%
Net debt HK$156M FY2025

Figures from reported company fundamentals · as of Aug 6, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 67/100

Of which business quality 68 · Market factors (momentum, volatility) 17

Profitability 58
Margins and returns on capital today
Quality Growth 68
Are margins and returns improving?
Cashflow 99
Earnings quality: real cash, not paper profit
Fin. Strength 58
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 29
Calm price path (market factor)
Momentum 15
Price trend over the last 3–12 months (market factor)
52W Momentum 8
Distance to the 52-week high (market factor)
Net Issuance 76
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China. It offers traditional beauty, aesthetic medical, subhealth assessment; and intervention services. The company markets its products under the Beauty Farm, Palaispa, Neology, and CellCare brand names.

Full company description

Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China. It offers traditional beauty, aesthetic medical, subhealth assessment; and intervention services. The company markets its products under the Beauty Farm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Beauty Farm Medical and Health Industry Inc reported revenue of HK$3.0B in FY2025 versus HK$1.8B in FY2021, a compound +13.9%/yr. Reported net income was HK$318M in FY2025, compounding +13.2%/yr from FY2021.

Growth Quality 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
HK$3.0B
Latest YoY
+16.7%
Avg. growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+22.4%
Avg. growth/yr (5Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+14.8%
Avg. growth/yr (6Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.5%
Revenue +13.9%/yr
FY21 HK$1.8B
FY22 HK$1.6B
FY23 HK$2.1B
FY24 HK$2.6B
FY25 HK$3.0B
Net income +13.2%/yr
FY21 HK$193M
FY22 HK$103M
FY23 HK$216M
FY24 HK$228M
FY25 HK$318M

Watch 2373: get an alert when its fair value changes →

Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Beauty Farm Medical and Health Industry Inc · Fair Value
HK$32.68 +68%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Beauty Farm Medical and Health Industry Inc Fair Value". https://www.fairvalue-calculator.com/stock/2373

Peer Group

Medical Care Facilities · 261 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 67 · Top 25%
Fair Value upside +68% · Top 25%
Return on equity (TTM) 33% · Top 25%
Return on assets 6% · Above median
Net margin (TTM) 11% · Above median
Operating margin (TTM) 16% · Top 25%
Revenue growth 8% · Above median
Dividend yield (TTM) 3.7% · Top 25%
Debt / equity 0.63× · Higher than 75% of peers

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/E (TTM) 10.1× · Cheaper than 75% of peers
P/B 3.89× · Pricier than 75% of peers
P/S (TTM) 1.33× · Pricier than median
P/FCF 0.5× · Cheaper than 75% of peers
EV/EBITDA 5.8× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 23
FUTURE 38 · sector 24
PAST 100 · sector 30
HEALTH 69 · sector 90
DIVIDEND 75 · sector 38

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 6, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $378.85 $554.93 +46%
Fresenius SE FRE €41.73 €32.15 -23%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.58 SGD 1.44 SGD -44%
Tenet Healthcare Corporation THC $194.91 $338.05 +73%
Rede D'Or São Luiz S.A RDOR3 R$36.01 R$47.31 +31%
DaVita Inc DVA $231.61 $255.97 +11%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,955 ₹2,955 -67%
Fresenius Medical Care AG FMS $24.68 $45.60 +85%
Aier Eye Hospital Group 300015 ¥8.68 ¥7.67 -12%

Compare Beauty Farm Medical and Health Industry Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Beauty Farm Medical and Health Industry Inc (2373) overvalued or undervalued?
As of Aug 6, 2026, our model estimates a fair value of HK$32.68 versus a price of HK$19.48, about +68% (undervalued).
What is the fair value of 2373?
Our model-based fair value for Beauty Farm Medical and Health Industry Inc is HK$32.68 (as of Aug 6, 2026), built from audited fundamentals. The current price is HK$19.48.
What is the quality score of 2373?
Beauty Farm Medical and Health Industry Inc has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Beauty Farm Medical and Health Industry Inc (2373)?
Beauty Farm Medical and Health Industry Inc reported trailing-twelve-month revenue of about HK$3.0B (latest available figure, as of Aug 6, 2026).
What is the net profit margin of 2373?
The net profit margin of Beauty Farm Medical and Health Industry Inc is about 10.6%, meaning it keeps roughly 10.6% of revenue as net income. Based on the latest reported figures.
Does Beauty Farm Medical and Health Industry Inc pay a dividend?
Beauty Farm Medical and Health Industry Inc currently shows a dividend yield of about 3.73% relative to its recent price (as of Aug 6, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Beauty Farm Medical and Health Industry Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.